Clinical Trial Update: Medico-economic Evaluation of Therapeutic Adaptation Guided by the Soluble Suppression of Tumorigenicity 2 (sST-2) Biomarker in the Management of Patients With Acute Heart Failure [NA]

View source ↗

Summary

A recruiting clinical trial is evaluating the medico-economic impact of a therapeutic adaptation guided by the soluble ST2 biomarker in acute heart failure. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Heart Failure | NA | Status: RECRUITING